BioCryst’s BCX4430 completely protected non-human primate from Marburg 48 hours post-infection
PRESS RELEASE BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced the online publication in the journal NatureĀ of extensive laboratory and nonclinical characterizations of BCX4430, including efficacy results More...